Hirokazu Murakami
- Hematology top 0.5%
- Molecular Biology top 10%
- Immunology top 5%
- Pathology and Forensic Medicine top 2%
- Genetics top 2%
- Co-authors
- Hiroshi HandaNorifumi TsukamotoTakayuki SaitohYoshihisa NojimaMorio SawamuraAkihiko YokohamaTakafumi MatsushimaHatsue Ogawara
- Topics
- Multiple Myeloma Research and Treatments (59 papers)Lymphoma Diagnosis and Treatment (35 papers)Acute Myeloid Leukemia Research (29 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hirokazu Murakami
191 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 109
- Hematology 1.3k
- Molecular Biology 885
- Immunology 560
- Pathology and Forensic Medicine 530
- Genetics 478
Countries citing papers authored by Hirokazu Murakami
This map shows the geographic impact of Hirokazu Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Murakami more than expected).
Fields of papers citing papers by Hirokazu Murakami
This network shows the impact of papers produced by Hirokazu Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Murakami. The network helps show where Hirokazu Murakami may publish in the future.
Co-authorship network of co-authors of Hirokazu Murakami
This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Murakami. A scholar is included among the top collaborators of Hirokazu Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Murakami. Hirokazu Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 11 | |
| 5 | 19 | |
| 6 | 14 | |
| 7 | 9 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 9 | |
| 11 | [Diagnosis and management guideline for multiple myeloma]. | 0 |
| 12 | 17 | |
| 13 | 10 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 74 | |
| 17 | 10 | |
| 18 | 6 | |
| 19 | 1 | |
| 20 | 13 |
About Hirokazu Murakami
Hirokazu Murakami is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 204 papers that have together received 2.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (59 papers), Lymphoma Diagnosis and Treatment (35 papers) and Acute Myeloid Leukemia Research (29 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (478 citations) and Pathology and Forensic Medicine (530 citations). Hirokazu Murakami has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroshi Handa, Norifumi Tsukamoto, Takayuki Saitoh, Yoshihisa Nojima, Morio Sawamura, Akihiko Yokohama, Takafumi Matsushima, Hatsue Ogawara, Jun‐ichi Tamura and Takuji Naruse. Their work appears in journals such as Blood, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.